Sarepta Therapeutics (SRPT) Cash from Investing Activities (QoQ) (2010 - 2026)
Sarepta Therapeutics (SRPT) Cash from Investing Activities (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Sarepta Therapeutics | 1.69 Bn | 1.28 Bn | 622.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -239.69% |
| Dec 31, 2025 | -58.60% |
| Sep 30, 2025 | 621.49% |
| Jun 30, 2025 | 111.06% |
| Mar 31, 2025 | -138.11% |
| Dec 31, 2024 | 693.14% |
| Sep 30, 2024 | -30.75% |
| Jun 30, 2024 | -145.03% |
| Mar 31, 2024 | 439.97% |
| Dec 31, 2023 | 69.44% |
| Sep 30, 2023 | -317.91% |
| Jun 30, 2023 | 673.57% |
| Mar 31, 2023 | 27.52% |
| Dec 31, 2022 | -48.76% |
| Sep 30, 2022 | 106.59% |
| Jun 30, 2022 | 63.10% |
| Mar 31, 2022 | -30,393.09% |
| Dec 31, 2021 | -112.72% |
| Sep 30, 2021 | -93.69% |
| Jun 30, 2021 | 104.93% |